Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$22.97 - $30.58 $3.1 Million - $4.13 Million
135,000 New
135,000 $3.69 Million
Q1 2023

May 15, 2023

BUY
$30.21 - $48.1 $2.1 Million - $3.34 Million
69,400 Added 77.11%
159,400 $5.3 Million
Q4 2022

Feb 14, 2023

BUY
$22.28 - $38.71 $1.19 Million - $2.07 Million
53,400 Added 145.9%
90,000 $2.76 Million
Q3 2022

Nov 14, 2022

BUY
$34.2 - $51.69 $1.25 Million - $1.89 Million
36,600 New
36,600 $1.28 Million
Q1 2022

May 13, 2022

SELL
$27.77 - $64.4 $3.52 Million - $8.15 Million
-126,600 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$54.9 - $105.21 $87,840 - $168,336
1,600 Added 1.28%
126,600 $7.96 Million
Q3 2021

Nov 12, 2021

BUY
$105.0 - $178.37 $315,000 - $535,110
3,000 Added 2.46%
125,000 $13.2 Million
Q2 2021

Aug 12, 2021

BUY
$125.11 - $180.0 $4.44 Million - $6.39 Million
35,500 Added 41.04%
122,000 $21.6 Million
Q1 2021

May 12, 2021

BUY
$126.27 - $191.71 $6.79 Million - $10.3 Million
53,800 Added 164.53%
86,500 $11.5 Million
Q4 2020

Feb 16, 2021

SELL
$81.94 - $135.34 $10.5 Million - $17.4 Million
-128,500 Reduced 79.71%
32,700 $4.43 Million
Q3 2020

Nov 16, 2020

SELL
$73.3 - $89.48 $1.02 Million - $1.24 Million
-13,900 Reduced 7.94%
161,200 $13.4 Million
Q2 2020

Aug 13, 2020

BUY
$48.82 - $82.53 $1.03 Million - $1.74 Million
21,100 Added 13.7%
175,100 $14.4 Million
Q1 2020

May 14, 2020

BUY
$39.1 - $62.9 $1.3 Million - $2.09 Million
33,218 Added 27.5%
154,000 $7.93 Million
Q4 2019

Feb 14, 2020

BUY
$29.79 - $43.06 $2.7 Million - $3.91 Million
90,782 Added 302.61%
120,782 $5.02 Million
Q3 2019

Nov 14, 2019

SELL
$30.47 - $37.65 $2.13 Million - $2.64 Million
-70,000 Reduced 70.0%
30,000 $971,000
Q2 2019

Aug 14, 2019

BUY
$25.73 - $35.79 $1.8 Million - $2.51 Million
70,000 Added 233.33%
100,000 $3.49 Million
Q1 2019

May 15, 2019

BUY
$21.71 - $31.54 $651,300 - $946,200
30,000 New
30,000 $885,000

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $2.59B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Bellevue Group Ag Portfolio

Follow Bellevue Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.